Internal Medicine, Hematology · Columbus, OH
NPI
1184996829
Since 2012
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
460 W 10th Ave Fl 5
Columbus, OH, 43210
Phone (614) 293-3196
Groups this clinician bills Medicare through
Medicare paid, 2024
$20K
261 services
Medicare patients, 2024
59
Average age 64
Drug cost, 2024
$4.8M
389 prescriptions
Company payments, 2025
$17K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hannah K Choe was code 99233 (hospital e&m - subsequent), 110 times for 24 patients. In total Hannah K Choe billed 261 services in 10 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 110 | 24 | $89.83 | $9,881 |
| 99215 Office E&M - Established | Facility | 75 | 38 | $100.17 | $7,513 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 52 | 32 | $12.28 | $639 |
By year: 2022 $21K for 230 services; 2023 $22K for 227 services; 2024 $20K for 261 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hannah K Choe prescribed most often to Medicare patients was Jakafi (Ruxolitinib Phosphate), with 169 prescriptions and refills. In total Hannah K Choe wrote 389 Medicare prescriptions that cost $4.8M.
Brand drugs: 281 claims; generic drugs: 108 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hannah K Choe $17K ($10K in general payments such as food, travel and fees and $6,725 for research) from 8 companies. The largest payer was Abbvie Inc. with $6,725.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.